Assessment of Antidiabetic and Anti-Inflammatory Activities of Carissa carandas Linn Extract: In Vitro and In Vivo Study
Applied Sciences · 25.05.2023 · 13 (11) · 6454
DOI: 10.3390/app13116454 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Sciences, online erschienen am 25.05.2023. Verfasst von Manaschanok Lailerd und 4 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Science Research and Innovation (TSRI) and Ampol Food Processing Co., Ltd., Faculty of Medicine Research Fund.
Abstract (Originalsprache)
This study investigated the effects of aqueous fruit extracts of Carissa carandas (CCA) on inflammation and insulin resistance using an in vitro cellular model, in vivo high-fat diets, and a streptozotocin-induced type 2 diabetic (T2DM) rat model. CCA significantly ameliorated inflammation by decreasing nitric oxide production in lipopolysaccharide (LPS)-induced RAW 264.7 macrophages. Interestingly, CCA showed anti-insulin resistance activities, as it significantly improved glucose uptake and decreased glycerol release in LPS-induced 3T3-L1 adipocytes. In vivo studies showed that a high dose of 12-week oral supplementation of CCA (400 mg/kg BW/day) significantly reduced visceral fat, triglycerides, and cholesterol level in the blood of diabetic rats. Importantly, the metabolic parameters in both fasting and postprandial states, including fasting plasma glucose, HOMA-IR, and glucose intolerance, significantly improved, indicating its antihyperglycemic benefit in diabetic rats. Moreover, the results of the HOMA-β and histological examination suggested that pancreatic β-cell function and pancreatic morphological changes of the CCA and metformin treatments appeared to be better than those in non-treated diabetes, indicating the protective effect of CCA against pancreatic damage caused by hyperglycemia. In conclusion, the present study first reported that the C. carandas fruit extract has anti-inflammation and anti-insulin resistance, and subsequently improved glycemic control in the T2DM rat model.
Förderung
- Thailand Science Research and Innovation (TSRI) and Ampol Food Processing Co., Ltd.
- Faculty of Medicine Research Fund
Zitieren
APA
Lailerd, M., Linn, T. W., Lailerd, N., Amornlerdpison, D., & Imsumran, A. (2023). Assessment of Antidiabetic and Anti-Inflammatory Activities of Carissa carandas Linn Extract: In Vitro and In Vivo Study. Applied Sciences, 13(11), 6454. https://doi.org/10.3390/app13116454
Vancouver
Lailerd M, Linn TW, Lailerd N, Amornlerdpison D, Imsumran A. Assessment of Antidiabetic and Anti-Inflammatory Activities of Carissa carandas Linn Extract: In Vitro and In Vivo Study. Applied Sciences. 2023;13(11):6454. doi:10.3390/app13116454
BibTeX
@article{Lailerd2023,
author = {Lailerd, Manaschanok and Linn, Thiri Wai and Lailerd, Narissara and Amornlerdpison, Duangporn and Imsumran, Arisa},
title = {Assessment of Antidiabetic and Anti-Inflammatory Activities of Carissa carandas Linn Extract: In Vitro and In Vivo Study},
journal = {Applied Sciences},
year = {2023},
volume = {13},
number = {11},
pages = {6454},
doi = {10.3390/app13116454}
}
EUVIMED